View in EDS PDF Full Text

Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.

Saved in:
Bibliographic Details
Title: Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.
Authors: Mispelbaum R; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Hattenhauer T; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Bauernfeind FG; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Lau JF; Institute of Pathology, University Hospital Bonn (UKB), Bonn, Germany., Brossart P; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Heine A; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Source: Frontiers in oncology [Front Oncol] 2024 Jun 10; Vol. 14, pp. 1406616. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38915369
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mispelbaum+R%22">Mispelbaum R</searchLink>; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Hattenhauer+T%22">Hattenhauer T</searchLink>; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Bauernfeind+FG%22">Bauernfeind FG</searchLink>; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Lau+JF%22">Lau JF</searchLink>; Institute of Pathology, University Hospital Bonn (UKB), Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Brossart+P%22">Brossart P</searchLink>; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Heine+A%22">Heine A</searchLink>; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Jun 10; Vol. 14, pp. 1406616. <i>Date of Electronic Publication: </i>2024 Jun 10 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38915369
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2024.1406616
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1406616
    Titles:
      – TitleFull: Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mispelbaum R
      – PersonEntity:
          Name:
            NameFull: Hattenhauer T
      – PersonEntity:
          Name:
            NameFull: Bauernfeind FG
      – PersonEntity:
          Name:
            NameFull: Lau JF
      – PersonEntity:
          Name:
            NameFull: Brossart P
      – PersonEntity:
          Name:
            NameFull: Heine A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 06
              Text: 2024 Jun 10
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1